Innovative Research for Effective Treatments
There are only innovations and medical advances with research! LDRTC is one of the few lysosomal and rare disorders medical facilities in the U.S. that combines Translational Research, Clinical Trials, and Treatment Center in one site. By incorporating these branches, we optimize medical care, improving the quality of many lives.
The LDRTC team of researchers and experts work together to maximize the efficiency of studies and discover better treatment options for those suffering from Lysosomal and Rare disorders.
LDRTC is home for rare, and we understand that each patient has their own medical needs. With that in mind, our Translational Research Center focuses on identifying novel biomarkers to analyze how individuals with these disorders respond to treatments.
With over 65 published studies, we thrive to keep making medical advances and help the lysosomal and rare disorders community live a better life.
Translational Research Unit oversees the bench-to-bedside research, develops and runs the study protocols. Our main discoveries have been discerning immune pathologies of lysosomal diseases and optimizing cellular models to study autophagy and other lysosomal functions. In addition, LDRTC recently conducted a large-scale screening program to study the incidence rates of common lysosomal disorders in the minority population in the D.C. metro area.
The Translational Research department is responsible for organizing LDRTC's annual Genetic Rare & Immune Disorders Symposium (GRIDS). This world-renowned event brings together the leading experts, researchers, and patient advocates in the field with the latest updates on lysosomal and rare disorders.